These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18195094)

  • 21. Polycythemia vera: scientific advances and current practice.
    Tefferi A; Spivak JL
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance.
    Park CH; Lee KO; Jang JH; Jung CW; Kim JW; Kim SH; Kim HJ
    J Clin Pathol; 2016 Aug; 69(8):737-41. PubMed ID: 27198504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera.
    Nussenzveig RH; Burjanivova T; Salama ME; Ogilvie NW; Marcinek J; Plank L; Agarwal AM; Perkins SL; Prchal JT
    Leuk Lymphoma; 2012 Dec; 53(12):2479-86. PubMed ID: 22642932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.
    Yoshinaga K; Mori N; Wang YH; Tomita K; Shiseki M; Motoji T
    Int J Hematol; 2008 Jul; 88(1):82-87. PubMed ID: 18528646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convergent mechanisms of somatic mutations in polycythemia vera.
    Wang K; Swierczek S; Hickman K; Hakonarson H; Prchal JT
    Discov Med; 2011 Jul; 12(62):25-32. PubMed ID: 21794206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
    Menier C; Guillard C; Cassinat B; Carosella ED; Rouas-Freiss N
    Leukemia; 2008 Mar; 22(3):578-84. PubMed ID: 18059484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel JAK2 exon 12 mutation identified in the retrospective analysis of paraffin-embedded tissues of polycythemia vera patients.
    Burjanivova T; Marcinek J; Lasabova Z; Minarik G; Szepe P; Balharek T; Vanochova A; Polacek H; Plank L
    Diagn Mol Pathol; 2009 Jun; 18(2):108-11. PubMed ID: 19430293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study.
    Vannucchi AM; Verstovsek S; Guglielmelli P; Griesshammer M; Burn TC; Naim A; Paranagama D; Marker M; Gadbaw B; Kiladjian JJ
    Ann Hematol; 2017 Jul; 96(7):1113-1120. PubMed ID: 28456851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic JAK-2 V617F Mutational Analysis in Polycythemia Rubra Vera: a Tertiary Care Center Experience.
    Sultan S; Irfan SM; Khan SR
    Asian Pac J Cancer Prev; 2016; 17(3):1053-5. PubMed ID: 27039724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.
    Ugo V; Tondeur S; Menot ML; Bonnin N; Le Gac G; Tonetti C; Mansat-De Mas V; Lecucq L; Kiladjian JJ; Chomienne C; Dosquet C; Parquet N; Darnige L; Porneuf M; Escoffre-Barbe M; Giraudier S; Delabesse E; Cassinat B;
    PLoS One; 2010 Jan; 5(1):e8893. PubMed ID: 20126644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.
    Yoo JH; Park TS; Maeng HY; Sun YK; Kim YA; Kie JH; Cho EH; Song J; Lee KA; Suh B; Choi JR
    Cancer Genet Cytogenet; 2009 Feb; 189(1):43-7. PubMed ID: 19167611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
    Manshouri T; Quintás-Cardama A; Nussenzveig RH; Gaikwad A; Estrov Z; Prchal J; Cortes JE; Kantarjian HM; Verstovsek S
    Cancer Sci; 2008 Jun; 99(6):1265-73. PubMed ID: 18482053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High percentage of JAK2 exon 12 mutation in Asian patients with polycythemia vera.
    Yeh YM; Chen YL; Cheng HY; Su WC; Chow NH; Chen TY; Ho CL
    Am J Clin Pathol; 2010 Aug; 134(2):266-70. PubMed ID: 20660330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.
    Martínez-Avilés L; Besses C; Alvarez-Larrán A; Cervantes F; Hernández-Boluda JC; Bellosillo B
    Haematologica; 2007 Dec; 92(12):1717-8. PubMed ID: 18056003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.
    Pietra D; Li S; Brisci A; Passamonti F; Rumi E; Theocharides A; Ferrari M; Gisslinger H; Kralovics R; Cremonesi L; Skoda R; Cazzola M
    Blood; 2008 Feb; 111(3):1686-9. PubMed ID: 17984312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.
    Lippert E; Boissinot M; Kralovics R; Girodon F; Dobo I; Praloran V; Boiret-Dupré N; Skoda RC; Hermouet S
    Blood; 2006 Sep; 108(6):1865-7. PubMed ID: 16728702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.
    Ibrahim IK; Hassan R; Ali EW; Omer A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):41-44. PubMed ID: 30677867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.
    Scott LM; Scott MA; Campbell PJ; Green AR
    Blood; 2006 Oct; 108(7):2435-7. PubMed ID: 16772604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera.
    Ishii T; Bruno E; Hoffman R; Xu M
    Blood; 2006 Nov; 108(9):3128-34. PubMed ID: 16757685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.